Inventor · disambiguated record
Andrei Golosov
Also filed as: GOLOSOV ANDREI · GOLOSOV ANDREI ALEXANDROVICH
9 granted patents·7 pending applications·76 citations·filing 2010–2024
85Inventor score
Top patents by PatentIndex Score
16 records- 0195US8673848B2Synthetic apelin mimetics for the treatment of heart failureZECRI FREDERIC·Filed 2013·Granted Mar 18, 2014·53 cites·27 claims
- 0284US9067971B2Synthetic apelin mimetics for the treatment of heart failureZECRI FREDERIC·Filed 2014·Granted Jun 30, 2015·9 cites·18 claims
- 0381US9982017B2Synthetic apelin mimetics for the treatment of heart failureNOVARTIS AG·Filed 2015·Granted May 29, 2018·3 cites·17 claims
- 0478US8802827B2AX1 PCSK9 antagonistsLUO PETER PEIZHI·Filed 2010·Granted Aug 12, 2014·6 cites·9 claims
- 0575US11999802B2Compositions and methods for selective protein degradationNOVARTIS AG·Filed 2018·Granted Jun 4, 2024·1 cites·33 claims
- 0671US2024384007A1Compositions and methods for selective protein degradationNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0770US8877900B2AX132 PCSK9 antagonistsLUO PETER PEIZHI·Filed 2010·Granted Nov 4, 2014·4 cites·9 claims
- 0861US11813306B2Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disordersNOVARTIS AG·Filed 2021·Granted Nov 14, 2023·0 cites·20 claims
- 0959US11026993B2Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disordersNOVARTIS AG·Filed 2019·Granted Jun 8, 2021·0 cites·33 claims
- 1054US2025090699A1Fap targeting cyclic peptides and conjugates thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1152US12209144B2Cyclic peptides as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disordersNOVARTIS AG·Filed 2019·Granted Jan 28, 2025·0 cites·1 claims
- 1246US2023089867A1Cyclic pentamer compounds as proprotein convertase subtilisin/kexin type 9 (pcsk9) inhibitors for the treatment of metabolic disorderNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1340US2022251152A1Compositions and methods for selective protein degradationNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1440US2016166634A1Bioconjugates of synthetic apelin polypeptidesCAPLAN SHARI LYNN·Filed 2016·Application pending·0 cites
- 1537US2023071283A1Compositions and methods for selective protein expressionGOLOSOV ANDREI·Filed 2017·Application pending·0 cites
- 1635US2016297854A1Compositions and methods for long acting moleculesGHOSH JOY·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →